We recently compiled a list of the 12 Best Long-Term Stocks to Buy According to Ken Fisher. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other long-term stocks.
Ken Fisher is a prominent American billionaire investment analyst, author, and the founder of Fisher Asset Management, one of the biggest and most successful hedge funds in the world. Fisher was born in California in 1950. His net worth is estimated at over $11.2 billion, ranking him high on the list of richest Americans and global billionaires. Fisher’s early life was influenced by his father, Philip A. Fisher, a renowned stock investor. He pursued higher education at California State Polytechnic University, Humboldt, graduating in 1972 with an associate degree in economics. In 1979, Fisher founded Fisher Investments, which has grown into a global financial advisory firm managing close to $252 billion in 13F securities.
Read more about these developments by accessing 10 Best AI Data Center Stocks and 10 Buzzing AI Stocks According to Goldman Sachs.
Fisher’s influence extends beyond asset management. He authored the Portfolio Strategy column in Forbes from 1984 to 2016, making him the longest continuously running columnist in the magazine’s history. Currently, he contributes monthly columns to major publications worldwide, including the New York Post, The Daily Telegraph, and The Australian, among others. In addition to his columns, Fisher has authored 11 books on investing, with four becoming New York Times bestsellers. His work has significantly influenced investment strategies and financial planning. Notably, he popularized the price-to-sales ratio as a stock analysis tool and has been involved in groundbreaking work in behavioral finance.
Read more about these developments by accessing 30 Most Important AI Stocks According to BlackRock and Beyond the Tech Giants: 35 Non-Tech AI Opportunities.
For this article, we selected stocks by combing through the 13F portfolio of Fisher Asset Management at the end of the fourth quarter of 2024. Only the companies that have been in the 13F portfolio of the fund consistently for the past three years were selected. These stocks are also popular among other hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
An array of pharmaceutical pills with the company’s logo on the bottle.
Eli Lilly and Company (NYSE:LLY)
Number of Hedge Fund Holders: 115
Fisher Asset Management’s Stake: $4 billion
Eli Lilly and Company (NYSE:LLY) develops and markets human pharmaceuticals. Revenue in the fourth quarter of 2024 increased 45% to $13.53 billion, driven by volume growth from Mounjaro and Zepbound, and non-incretin revenue grew by 20% compared to the fourth quarter of the previous year. In February, the company announced results from the VIVID-2 study, showing that most patients with moderately to severely active Crohn’s disease achieved long-term clinical and endoscopic improvements after two years of continuous treatment with Omvoh. It includes 43.8% of patients who had previously failed biological treatments. In February, Jomfruland reported that the company is revolutionizing diabetes care with an AI-driven metabolic analysis platform that personalizes glucose management, improving medication effectiveness and patient outcomes.
Overall LLY ranks 9th on our list of the best long-term stocks to buy according to Ken Fisher. While we acknowledge the potential of LLY as an investment, our conviction lies in the belief that some stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for a stock that is more promising than LLY but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap
Disclosure: None. This article is originally published at Insider Monkey.
